Delivery Order SPE2DR25D3017-SPE2DR26F3EN5
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,180.52 on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,381.44. This is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,374.50 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $3,164.74. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $2,325.92, with completion targeted for October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,744.44 on November 20, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors (0.5 mL dosage). This firm fixed-price delivery order is scheduled for completion by November 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made competitively without any set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $15,344.90. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.89 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injectors on December 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 11, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,228.84 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive set-aside and is scheduled for completion by August 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location in the same...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EN5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with a ceiling value of $2,907.40. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. Trulicity, a diabetes medication, represents one of many therapeutic categories within the company's extensive federal contract portfolio. The DLA Troop Support Medical prime vendor program enables AmerisourceBergen to provide pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally, positioning the company as a major supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/10/25 |